This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Southern California. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Pang-Yu Hsueh
Introduction
Pang-Yu Hsueh is an accomplished inventor based in San Jose, CA. He has made significant contributions to the field of drug delivery systems through his innovative research and patents. His work focuses on developing methods and therapeutics that utilize elastin-like peptides for targeted drug delivery.
Latest Patents
Pang-Yu Hsueh holds a patent for "Methods and therapeutics comprising ligand-targeted ELPs." This patent discloses novel methods and compositions for targeting drug delivery systems to specific cells. One aspect of his invention relates to a drug delivery system that includes an elastin-like peptide (ELP) component and a ligand selected from a specific group. The ligand is designed to bind to receptors such as the coxsackievirus and adenovirus receptor (CAR) and the polymeric immunoglobulin receptor (pIgR). His work highlights the transcytosing properties of elastin-like peptides and their potential in pharmaceutical applications.
Career Highlights
Pang-Yu Hsueh is affiliated with the University of Southern California, where he continues to advance his research in drug delivery systems. His innovative approach has garnered attention in the scientific community, leading to valuable contributions in the field.
Collaborations
Pang-Yu has collaborated with notable colleagues, including Sarah Hamm-Alvarez and John Andrew MacKay. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Pang-Yu Hsueh's work in developing targeted drug delivery systems showcases his innovative spirit and dedication to advancing medical therapeutics. His contributions are paving the way for more effective treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
